tm
Seeing Is Believing
tm
Seeing Is Believing
RNAC is currently covered by 4 analysts with an average price target of $34.5. This is a potential upside of $26.51 (232.37%) from yesterday's end of day stock price of $10.38.
Cartesian Therapeutics's activity chart (see below) currently has 62 price targets and 49 ratings on display. The stock rating distribution of RNAC is 88.89% BUY and 11.11% HOLD.
Highest price target for RNAC is $44, Lowest price target is $16, average price target is $34.5.
Most recent stock forecast was given by MARTIN FAN from WEDBUSH on 18-Aug-2026. First documented stock forecast 11-Mar-2024.
Currently out of the existing stock ratings of RNAC, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Jul-2025
$38
$27.96 (278.49%)
$38
Buy Since 08-May-2024
$40
$30.58 (324.63%)
$40
Buy Since 19-Dec-2024
$44
$34.58 (367.09%)
$44
Hold Since 09-Mar-2026
$16
$6.58 (69.85%)
$22
Buy Since 11-Mar-2024
$40
$30.58 (324.63%)
$40
What is RNAC (Cartesian Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RNAC (Cartesian Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RNAC (Cartesian Therapeutics)?
Which analyst is the currently most bullish on RNAC (Cartesian Therapeutics)?
Which analyst is the currently most reserved on RNAC (Cartesian Therapeutics)?
